OUTCOMES OF SALVAGE CHEMOTHERAPY REGIMENS IN CHILDREN AND ADOLESCENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML)

被引：0
|
作者：
Tak, Himangi [1 ]
Trivedi, Maharshi [1 ]
Joshi, Nitin [1 ]
Panchal, Harsha [1 ]
机构：
[1] Gujarat Canc Res Inst, Dept Pediat & Med Oncol, Ahmadabad, Gujarat, India
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO026
引用
下载
收藏
页码：S553 / S553
页数：1
相关论文
共 50 条
  • [1] Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia
    Mushtaq, Muhammad Umair
    Chaudhary, Sibgha Gull
    Michaelis, Laura C.
    Carlson, Karen-Sue B.
    Abedin, Sameem
    Runass, Lyndsey
    Fallon, Michael J.
    Harrington, Alexandra M.
    Juckett, Mark
    Hall, Aric C.
    Mattison, Ryan J.
    Atallah, Ehab L.
    Murthy, Guru Subramanian Guru
    BLOOD, 2018, 132
  • [2] Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia (AML).
    Thomas, M
    Koller, C
    Yang, Y
    Shen, Y
    O'Brien, S
    Kantarjian, H
    Davis, J
    Estey, E
    BLOOD, 2001, 98 (11) : 224B - 224B
  • [3] Gemtuzumab Ozogamicin Containing Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia (AML) in Children
    Liu, Anthony Pak-Yin
    Leung, Alex Wing-Kwan
    Cheuk, Daniel Ka-Leung
    Lee, Vincent
    Ha, Shau-Yin
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (02) : 163 - 168
  • [4] Propensity-score Matched Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia
    Reid, Justin H.
    Marini, Bernard L.
    Benitez, Lydia L.
    Pettit, Kristen
    Bixby, Dale L.
    Burke, Patrick
    Perissinotti, Anthony J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (06): : 393 - +
  • [5] Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia
    Bogdan Popescu
    Sheenu Sheela
    Julie Thompson
    Sophia Grasmeder
    Therese Intrater
    Christin B. DeStefano
    Christopher S. Hourigan
    Catherine Lai
    Clinical Hematology International, 2020, 2 (1) : 27 - 31
  • [6] Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia
    Mushtaq, Muhammad Umair
    Harrington, Alexandra M.
    Chaudhary, Sibgha Gull
    Michaelis, Laura C.
    Carlson, Karen-Sue B.
    Abedin, Sameem
    Runass, Lyndsey
    Callander, Natalie S.
    Fallon, Michael J.
    Juckett, Mark
    Hall, Aric C.
    Hematti, Peiman
    Mattison, Ryan J.
    Atallan, Ehab L.
    Murthy, Guru Subramanian Guru
    LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 158 - 166
  • [7] Efficacy of common salvage chemotherapy regimens in patients with refractory or relapsed acute myeloid leukemia A retrospective cohort study
    Xu, Jun
    Lv, Ting-Ting
    Zhou, Xiao-Fen
    Huang, Ying
    Liu, Dong-Dong
    Yuan, Guo-Lin
    MEDICINE, 2018, 97 (39)
  • [8] Salvage therapy for relapsed or refractory acute myeloid leukemia
    Mangan, James K.
    Luger, Selina M.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2011, 2 (02) : 73 - 82
  • [9] Comparison of Salvage Intensive Chemotherapy Versus Venetoclax Combined Regimen in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
    Park, Silvia
    Kim, Hee-Je
    Cho, Byung Sik
    Kim, Yoo-Jin
    Min, Gi June
    Park, Sung-Soo
    Yahng, Seung-Ah
    Jeon, Young-Woo
    Shin, Seung-Hwan
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Eom, Ki-Seong
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Lee, Jong Wook
    BLOOD, 2021, 138
  • [10] Differential Outcomes of Salvage with FLAG-IDA and Venetoclax-Based Regimens in Relapsed and Refractory Acute Myeloid Leukemia
    Bouligny, Ian M.
    Maher, Keri R.
    BLOOD, 2021, 138
12345